1. Home
  2. PHGE vs GRRR Comparison

PHGE vs GRRR Comparison

Compare PHGE & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GRRR
  • Stock Information
  • Founded
  • PHGE 2015
  • GRRR 2001
  • Country
  • PHGE Israel
  • GRRR United Kingdom
  • Employees
  • PHGE N/A
  • GRRR N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • PHGE Health Care
  • GRRR Technology
  • Exchange
  • PHGE Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • PHGE 26.5M
  • GRRR 28.7M
  • IPO Year
  • PHGE N/A
  • GRRR N/A
  • Fundamental
  • Price
  • PHGE $0.75
  • GRRR $4.32
  • Analyst Decision
  • PHGE Strong Buy
  • GRRR Buy
  • Analyst Count
  • PHGE 2
  • GRRR 1
  • Target Price
  • PHGE $22.50
  • GRRR $9.00
  • AVG Volume (30 Days)
  • PHGE 151.9K
  • GRRR 586.8K
  • Earning Date
  • PHGE 11-14-2024
  • GRRR 11-22-2024
  • Dividend Yield
  • PHGE N/A
  • GRRR N/A
  • EPS Growth
  • PHGE N/A
  • GRRR N/A
  • EPS
  • PHGE N/A
  • GRRR 2.28
  • Revenue
  • PHGE N/A
  • GRRR $78,940,347.00
  • Revenue This Year
  • PHGE N/A
  • GRRR $15.59
  • Revenue Next Year
  • PHGE N/A
  • GRRR $20.59
  • P/E Ratio
  • PHGE N/A
  • GRRR $1.89
  • Revenue Growth
  • PHGE N/A
  • GRRR 424.97
  • 52 Week Low
  • PHGE $0.62
  • GRRR $2.09
  • 52 Week High
  • PHGE $8.55
  • GRRR $13.00
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 36.37
  • GRRR 53.71
  • Support Level
  • PHGE $0.67
  • GRRR $4.16
  • Resistance Level
  • PHGE $0.81
  • GRRR $4.76
  • Average True Range (ATR)
  • PHGE 0.09
  • GRRR 0.32
  • MACD
  • PHGE 0.00
  • GRRR -0.02
  • Stochastic Oscillator
  • PHGE 44.00
  • GRRR 48.75

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About GRRR Gorilla Technology Group Inc. Ordinary shares

Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: